Tuesday , May 21 2019
Breaking News
Home / Author Archives: chundawat (page 10)

Author Archives: chundawat

U.S. Treasury’s Mnuchin rejects subpoena for Trump tax returns

In a widely expected move, Mnuchin rejected a demand for the documents from House Ways and Means Committee Chairman Richard Neal, saying the panel lacks “a legitimate legislative purpose” for obtaining the tax records that Democrats view as critical to their efforts to investigate Trump and his presidency. “We are ... Read More »

Two terrorists killed in J&K’s Pulwama encounter

In Jammu and Kashmir, two terrorists were killed in an encounter with security forces in Awantipora area of Pulwama district early morning on Saturday. The gunfight broke out after security forces launched cordon and search operation in Panzgam village and the terrorists hiding there opened fire on the soldiers. Another ... Read More »

General polls underway in Australia

Voting is underway in Australia’s first general election since political infighting ousted the nation’s fourth leader in a decade. Australia has mandatory voting and a record 16.4 million enrolled voters. Around 7,000 polling stations have been set up across the nation. Prime Minister Scott Morrison has made economic management the ... Read More »

Spencers Retail to acquire stake in Natures Basket

Spencers Retail has received approval for acquisition of 100% stake in Natures Basket, a Wholly Owned Subsidiary of Godrej Industries (GIL), subject to approval of the Shareholders of both the Companies. The Board of Directors of the Company at its meeting held on May 17, 2019 has approved the same. ... Read More »

Indian Hotels Company signs Taj hotel in Agra

The Indian Hotels Company (IHCL) has signed Taj branded hotel in Agra. This hotel is owned by Sincere Developers under a management contract by Taj. The hotel is strategically located within walking distance from the Taj Mahal and one of the three UNESCO World Heritage sites in Agra. The hotel ... Read More »

USFDA conducts inspection at Cipla’s Indore facility

The United States Food and Drug Administration (USFDA) has conducted a post-approval inspection at Cipla’s Indore facility from May 13 – 17, 2019. The inspection ended with zero observations. Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. ... Read More »